Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Coherus Oncology (CHRS) Asset Utilization Ratio (2016 - 2025)

Coherus Oncology's Asset Utilization Ratio history spans 12 years, with the latest figure at 0.11 for Q4 2025.

  • For Q4 2025, Asset Utilization Ratio fell 43.04% year-over-year to 0.11; the TTM value through Dec 2025 reached 0.11, down 43.04%, while the annual FY2025 figure was 0.12, 143.74% up from the prior year.
  • Asset Utilization Ratio for Q4 2025 was 0.11 at Coherus Oncology, up from 0.08 in the prior quarter.
  • Across five years, Asset Utilization Ratio topped out at 0.58 in Q1 2021 and bottomed at 0.08 in Q3 2025.
  • The 5-year median for Asset Utilization Ratio is 0.41 (2022), against an average of 0.36.
  • The largest annual shift saw Asset Utilization Ratio grew 3.65% in 2023 before it tumbled 73.78% in 2025.
  • A 5-year view of Asset Utilization Ratio shows it stood at 0.46 in 2021, then fell by 10.97% to 0.41 in 2022, then increased by 3.65% to 0.42 in 2023, then tumbled by 54.93% to 0.19 in 2024, then crashed by 43.04% to 0.11 in 2025.
  • Per Business Quant, the three most recent readings for CHRS's Asset Utilization Ratio are 0.11 (Q4 2025), 0.08 (Q3 2025), and 0.24 (Q2 2025).